TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
69.2%
Neutral
23.1%
Negative
7.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $34 |
51%
upside
| 6 | +4.8% |
0
%
| 4 Mar ‘26 5 days ago |
|
|
|
Neutral
Maintained
| $16 |
10%
downside
| 4 | – |
–
| 20 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $74 |
19%
upside
| 2 | +47% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $62 |
1%
downside
| 2 | +27% |
0
%
| 9 Jan ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $25 |
12%
downside
| 2 | – |
–
| 6 Jan ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $38 |
39%
upside
| 1 | +41% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $15 |
47%
upside
| 2 | -14% |
0
%
| 20 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $47 |
6%
upside
| 1 | +21% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Underweight
Downgraded
| $263 |
5,047%
upside
| 1 | -68% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $34 |
19%
upside
| 3 | +28% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | -112% |
0
%
| 16 Sep ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $10 |
34%
upside
| 1 | +159% |
0
%
| 30 May ‘25 9 months ago |
|